Literature DB >> 15105460

S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function.

Kenny K K Chung1, Bobby Thomas, Xiaojie Li, Olga Pletnikova, Juan C Troncoso, Laura Marsh, Valina L Dawson, Ted M Dawson.   

Abstract

Parkin is an E3 ubiquitin ligase involved in the ubiquitination of proteins that are important in the survival of dopamine neurons in Parkinson's disease (PD). We show that parkin is S-nitrosylated in vitro, as well as in vivo in a mouse model of PD and in brains of patients with PD and diffuse Lewy body disease. Moreover, S-nitrosylation inhibits parkin's ubiquitin E3 ligase activity and its protective function. The inhibition of parkin's ubiquitin E3 ligase activity by S-nitrosylation could contribute to the degenerative process in these disorders by impairing the ubiquitination of parkin substrates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105460     DOI: 10.1126/science.1093891

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  295 in total

Review 1.  S-nitrosylation: physiological regulation of NF-kappaB.

Authors:  Harvey E Marshall; Douglas T Hess; Jonathan S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-08       Impact factor: 11.205

2.  Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.

Authors:  Dongdong Yao; Zezong Gu; Tomohiro Nakamura; Zhong-Qing Shi; Yuliang Ma; Benjamin Gaston; Lisa A Palmer; Edward M Rockenstein; Zhuohua Zhang; Eliezer Masliah; Takashi Uehara; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-13       Impact factor: 11.205

Review 3.  Regulation by S-nitrosylation of protein post-translational modification.

Authors:  Douglas T Hess; Jonathan S Stamler
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

Review 4.  Regulation of Parkin E3 ubiquitin ligase activity.

Authors:  Helen Walden; R Julio Martinez-Torres
Journal:  Cell Mol Life Sci       Date:  2012-04-19       Impact factor: 9.261

Review 5.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

6.  Mitochondrial ubiquitin ligase MITOL blocks S-nitrosylated MAP1B-light chain 1-mediated mitochondrial dysfunction and neuronal cell death.

Authors:  Ryo Yonashiro; Yuya Kimijima; Takuya Shimura; Kohei Kawaguchi; Toshifumi Fukuda; Ryoko Inatome; Shigeru Yanagi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

7.  S-nitrosylated SHP-2 contributes to NMDA receptor-mediated excitotoxicity in acute ischemic stroke.

Authors:  Zhong-Qing Shi; Carmen R Sunico; Scott R McKercher; Jiankun Cui; Gen-Sheng Feng; Tomohiro Nakamura; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

8.  Endothelial Nitric Oxide Synthase-Derived Nitric Oxide Prevents Dihydrofolate Reductase Degradation via Promoting S-Nitrosylation.

Authors:  Zhejun Cai; Qiulun Lu; Ye Ding; Qilong Wang; Lei Xiao; Ping Song; Ming-Hui Zou
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-09-17       Impact factor: 8.311

Review 9.  Posttranslational modification and quality control.

Authors:  Xuejun Wang; J Scott Pattison; Huabo Su
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

Review 10.  Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance.

Authors:  Chun Zhou; Yong Huang; Serge Przedborski
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.